[{"orgOrder":0,"company":"Fisabio","sponsor":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz | Hospital Universitario General de Villalba | Hospital Universitario Infanta Elena | Hospital Universitario Virgen de la Arrixaca | Hospital Cl\u00ednico Universitario de Valencia | Dentaid","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"SPAIN","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Fisabio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fisabio \/ Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz | Hospital Universitario General de Villalba | Hospital Universitario Infanta Elena | Hospital Universitario Virgen de la Arrixaca | Hospital Cl\u00ednico Universitario de Valencia | Dentaid","highestDevelopmentStatusID":"1","companyTruncated":"Fisabio \/ Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz | Hospital Universitario General de Villalba | Hospital Universitario Infanta Elena | Hospital Universitario Virgen de la Arrixaca | Hospital Cl\u00ednico Universitario de Valencia | Dentaid"},{"orgOrder":0,"company":"Egymedicalpedia","sponsor":"Al-Azhar University","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"","productType":"Miscellaneous","year":"2024","type":"Inapplicable","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Egymedicalpedia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Egymedicalpedia \/ Al-Azhar University","highestDevelopmentStatusID":"1","companyTruncated":"Egymedicalpedia \/ Al-Azhar University"},{"orgOrder":0,"company":"Tropical Infectious Diseases Research and Education Center","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"THAILAND","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Preclinical","graph3":"Tropical Infectious Diseases Research and Education Center","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Gargle\/Mouthwash","sponsorNew":"Tropical Infectious Diseases Research and Education Center \/ Undisclosed","highestDevelopmentStatusID":"4","companyTruncated":"Tropical Infectious Diseases Research and Education Center \/ Undisclosed"},{"orgOrder":0,"company":"Mundipharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"GERMANY","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Preclinical","graph3":"Mundipharma","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Gargle\/Mouthwash","sponsorNew":"Mundipharma \/ Undisclosed","highestDevelopmentStatusID":"4","companyTruncated":"Mundipharma \/ Undisclosed"},{"orgOrder":0,"company":"Halodine","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Halodine","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Solution","sponsorNew":"Halodine \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Halodine \/ Undisclosed"},{"orgOrder":0,"company":"Veloce BioPharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Preclinical","graph3":"Veloce BioPharma","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Solution","sponsorNew":"Veloce BioPharma \/ Undisclosed","highestDevelopmentStatusID":"4","companyTruncated":"Veloce BioPharma \/ Undisclosed"},{"orgOrder":0,"company":"University of Iowa","sponsor":"3M Company","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"University of Iowa","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Swab","sponsorNew":"University of Iowa \/ 3M Company","highestDevelopmentStatusID":"11","companyTruncated":"University of Iowa \/ 3M Company"},{"orgOrder":0,"company":"Brigham and Women's Hospital","sponsor":"3M Company","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase I\/ Phase II","graph3":"Brigham and Women's Hospital","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Swab","sponsorNew":"Brigham and Women's Hospital \/ 3M Company","highestDevelopmentStatusID":"7","companyTruncated":"Brigham and Women's Hospital \/ 3M Company"},{"orgOrder":0,"company":"Hamilton Health Sciences","sponsor":"McMaster University","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CANADA","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"Hamilton Health Sciences","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Solution","sponsorNew":"Hamilton Health Sciences \/ McMaster University","highestDevelopmentStatusID":"10","companyTruncated":"Hamilton Health Sciences \/ McMaster University"},{"orgOrder":0,"company":"Hamilton Health Sciences","sponsor":"McMaster University | Ontario Clinical Oncology Group","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CANADA","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"Hamilton Health Sciences","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Solution","sponsorNew":"Hamilton Health Sciences \/ McMaster University | Ontario Clinical Oncology Group","highestDevelopmentStatusID":"10","companyTruncated":"Hamilton Health Sciences \/ McMaster University | Ontario Clinical Oncology Group"},{"orgOrder":0,"company":"Emery Pharma","sponsor":"Halodine","pharmaFlowCategory":"D","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Partnership","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Emery Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Solution","sponsorNew":"Emery Pharma \/ Halodine","highestDevelopmentStatusID":"1","companyTruncated":"Emery Pharma \/ Halodine"},{"orgOrder":0,"company":"Loreen Herwaldt","sponsor":"Indiana University | University of Utah | Washington University School of Medicine | University of Texas System | Gabrail Cancer Center Research | PDI Healthcare | Centers for Disease Control and Prevention","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Loreen Herwaldt","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Ointment","sponsorNew":"Loreen Herwaldt \/ Indiana University | University of Utah | Washington University School of Medicine | University of Texas System | Gabrail Cancer Center Research | PDI Healthcare | Centers for Disease Control and Prevention","highestDevelopmentStatusID":"11","companyTruncated":"Loreen Herwaldt \/ Indiana University | University of Utah | Washington University School of Medicine | University of Texas System | Gabrail Cancer Center Research | PDI Healthcare | Centers for Disease Control and Prevention"},{"orgOrder":0,"company":"Advantage Silver Dental Arrest","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase II","graph3":"Advantage Silver Dental Arrest","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Advantage Silver Dental Arrest \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Advantage Silver Dental Arrest \/ Undisclosed"}]

Find Clinical Drug Pipeline Developments & Deals for Isodine

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Egymedicalpedia

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Egymedicalpedia

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Details : Betadine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Surgical Wound Infection.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          September 19, 2024

                          Lead Product(s) : Povidone Iodine

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Undisclosed

                          Sponsor : Al-Azhar University

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          PackExpo
                          Not Confirmed
                          PackExpo
                          Not Confirmed

                          Details : Povidone Iodine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Prosthesis-Related Infections.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          November 13, 2023

                          Lead Product(s) : Povidone Iodine

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase III

                          Sponsor : McMaster University | Ontario Clinical Oncology Group

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Loreen Herwaldt

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Loreen Herwaldt

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Lead Product(s) : Povidone Iodine

                          Therapeutic Area : Infections and Infectious Diseases

                          Study Phase : Phase IV

                          Sponsor : Indiana University | University of Utah | Washington University School of Medicine | University of Texas System | Gabrail Cancer Center Research | PDI Healthcare | Centers for Disease Control and Prevention

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Povidone Iodine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Surgical Wound Infection.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          March 10, 2023

                          Lead Product(s) : Povidone Iodine

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase IV

                          Sponsor : Indiana University | University of Utah | Washington University School of Medicine | University of Texas System | Gabrail Cancer Center Research | PDI Healthcare | Centers for Disease Control and Prevention

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          University of Iowa

                          Country arrow
                          PackExpo
                          Not Confirmed

                          University of Iowa

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Details : Povidone Iodine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of COVID-19.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          February 27, 2023

                          Lead Product(s) : Povidone Iodine

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase IV

                          Sponsor : 3M Company

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          PackExpo
                          Not Confirmed
                          PackExpo
                          Not Confirmed

                          Details : Povidone Iodine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Prosthesis-Related Infections.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          October 19, 2021

                          Lead Product(s) : Povidone Iodine

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase III

                          Sponsor : McMaster University

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          Advantage Silver Dental Arrest

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Advantage Silver Dental Arrest

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Details : Povidone Iodine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dental Caries.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          July 01, 2021

                          Lead Product(s) : Povidone Iodine

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase II

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          Fisabio

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Fisabio

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Lead Product(s) : Povidone Iodine

                          Therapeutic Area : Infections and Infectious Diseases

                          Study Phase : Undisclosed

                          Sponsor : Hospital Universitario Fundación Jiménez Díaz | Hospital Universitario General de Villalba | Hospital Universitario Infanta Elena | Hospital Universitario Virgen de la Arrixaca | Hospital Clínico Universitario de Valencia | Dentaid

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Betadine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of COVID-19.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          January 13, 2021

                          Lead Product(s) : Povidone Iodine

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Undisclosed

                          Sponsor : Hospital Universitario Fundación Jiménez Díaz | Hospital Universitario General de Villalba | Hospital Universitario Infanta Elena | Hospital Universitario Virgen de la Arrixaca | Hospital Clínico Universitario de Valencia | Dentaid

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          Halodine

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Halodine

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Details : Povidone Iodine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of COVID-19.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          August 18, 2020

                          Lead Product(s) : Povidone Iodine

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase IV

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          Brigham and Women's Hospital

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Brigham and Women's Hospital

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Details : Povidone Iodine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of COVID-19.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          August 12, 2020

                          Lead Product(s) : Povidone Iodine

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : 3M Company

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          PackExpo
                          Not Confirmed
                          PackExpo
                          Not Confirmed

                          Details : This collaboration brings together Emery Pharma's years of experience in antimicrobial and antiviral screening and drug development with Halodine's expertise in topical antiviral drug development.

                          Product Name : Halodine

                          Product Type : Miscellaneous

                          Upfront Cash : Undisclosed

                          July 30, 2020

                          Lead Product(s) : Povidone Iodine

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Undisclosed

                          Sponsor : Halodine

                          Deal Size : Undisclosed

                          Deal Type : Partnership

                          blank